Product

MBS314

Aliases

MBS314 Injection

1 clinical trial

1 indication

Indication

Multiple Myeloma

Clinical trial

A Phase Ⅰ/Ⅱ Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of MBS314 Injection in Patients With Relapsed/Refractory Multiple Myeloma.

Status: Recruiting, Estimated PCD: 2026-02-01